Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments

Incomments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare& Medicaid Services (CMS) Medicaid proposed rule. Today, we ’re diving deeper intoCMS ’s proposal to vastly expand the types of medicines that would fall under the definition of a “line extension” and how that change threatens future development of needed cures and treatments by establishing a tax on innovation.

Source: The Catalyst - October 13, 2020 Category: Pharmaceuticals Tags: Research and Development HIV/AIDS Medicaid Mental Health Coronavirus Source Type: news